Cargando…
Probenecid as a sensitizer of bisphosphonate-mediated effects in breast cancer cells
BACKGROUND: Anti-resorptive bisphosphonates (BP) are used for the treatment of osteoporosis and bone metastases. Clinical studies indicated a benefit in survival and tumor relapse in subpopulations of breast cancer patients receiving zoledronic acid, thus stimulating the debate about its anti-tumor...
Autores principales: | Ebert, Regina, Meissner-Weigl, Jutta, Zeck, Sabine, Määttä, Jorma, Auriola, Seppo, Coimbra de Sousa, Sofia, Mentrup, Birgit, Graser, Stephanie, Rachner, Tilman D, Hofbauer, Lorenz C, Jakob, Franz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4295226/ https://www.ncbi.nlm.nih.gov/pubmed/25496233 http://dx.doi.org/10.1186/1476-4598-13-265 |
Ejemplares similares
-
1,25-Dihydroxyvitamin D3 Treatment Delays Cellular Aging in Human Mesenchymal Stem Cells while Maintaining Their Multipotent Capacity
por: Klotz, Barbara, et al.
Publicado: (2012) -
Liposome encapsulated zoledronate favours M1-like behaviour in murine macrophages cultured with soluble factors from breast cancer cells
por: Sousa, Sofia, et al.
Publicado: (2015) -
Fatal attraction: why breast cancer cells home to bone
por: Hofbauer, Lorenz C, et al.
Publicado: (2008) -
From bone to breast and back - the bone cytokine RANKL and breast cancer
por: Hofbauer, Lorenz C, et al.
Publicado: (2011) -
Targeting Bone Metabolism in Patients with Advanced Prostate Cancer: Current Options and Controversies
por: Todenhöfer, Tilman, et al.
Publicado: (2015)